This scheme supports the identification, validation, and implementation of clinical biomarkers that bring us closer to an early and accurate diagnosis, and/or inform the management of brain tumours.
In order to encourage collaboration between the laboratory and the clinic these grants will be awarded jointly to a Scientific lead and a Clinical lead researcher.
Call open: 25 June 2018
Application deadline: 03 Sept 2018
Funding decision: 11 March 2019
Call open: 07 January 2019
Application deadline: 18 March 2019
Funding decision: September 2019
These grants are available for up to £100,000 per year for up to five years.
Studies may make use of the samples and infrastructure brought about by funded clinical trials, to go beyond the primary and secondary endpoints and generate new knowledge around clinical biomarkers.
Applications must include a Clinical lead researcher and a Scientific lead researcher.
To obtain input from those affected by brain tumours, we strongly recommend that applicants access our Research Involvement Network (RIN) for public and patient involvement. In order to receive feedback from the RIN, please allow for a minimum of 3 weeks turnaround time.
These grant conditions, together with the grant award letter, set out the terms and conditions on which we make a grant to the host institution and grantholder.
These guidelines explain which of the costs incurred will be paid for by The Charity
This statement details how the information you give us will be processed, used and stored in accordance with data protection legislation
Please take note of, and allow sufficient time for, the approval steps required to complete the submission process. We cannot guarantee late submissions will be accepted.
If you would like to discuss project ideas or need any information, please contact the Research Team.
Phone: +44 (0) 1252 418190